Dr. Reddy's Launches Debiopharm's Pamorelin® LA in India for the Treatment of Locally Advanced or Metastatic, Hormone-Dependent Prostate Cancer
LAUSANNE, Switzerland, December 7, 2012 /PRNewswire/ --
Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, announces that Dr. Reddy's Laboratories Ltd. launched Pamorelin(R) LA in India for the treatment of locally advanced or metastatic, hormone-dependent prostate cancer on December 3.
Under the terms of the agreement, Dr. Reddy's acquires exclusive marketing and sales
To read the complete release at NewsBlaze,
Dr. Reddy's Launches Debiopharm's Pamorelin® LA in India for the Treatment of Locally Advanced or Metastatic, Hormone-Dependent Prostate Cancer,
Click here
Related PRNewswire Releases News
